Skip to main content
Erschienen in: Comparative Clinical Pathology 5/2020

01.08.2020 | Case Report

MDS/MPN with ringed sideroblasts and thrombocytosis, and secondary or concurrent mastocytosis: case report and literature review

verfasst von: Ismail Elbaz Younes, Dereen Mohammed Saeed, Nasma Majeed, David Hakimian, Redouane Boumendjel

Erschienen in: Comparative Clinical Pathology | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN with RS-T), which exhibits both an increased number of marrow ring sideroblasts and thrombocytosis, is a rare disorder classified as one of the newly established forms of MDS/MPN in the WHO 2016 classification. Systemic mastocytosis (SM) is a heterogeneous group of neoplasms characterized by growth and accumulation of both cytologically and immunophenotypically abnormal mast cells in one or more body organ systems. SM can occur as a separate neoplasm but commonly is associated with other clonally related myeloid neoplasms. Herein, we present a 78-year-old female with a clinical history of fatigue, dyspnea, and a compression fracture of L5. Her peripheral blood, bone marrow aspirate, and biopsy laboratory workup show features of myelodysplasia with ring sideroblasts, thrombocytosis, and clusters of mast cells in the bone marrow biopsy. Pathogenic c-KIT, MPL, and SF3B1 genes are identified by the molecular study. We present this case to point out a rare combination of systemic mastocytosis and MDS/MPN with ring sideroblasts and thrombocytosis. It is not known if the best treatment should be focused on the systemic mastocytosis or the accompanying MDS/MPN.
Literatur
Zurück zum Zitat Bernd H-W, Sotlar K, Lorenzen J, Osieka R, Fabry U, Valent P, Horny HP (2004) Acute myeloid leukaemia (AML) with t(8;21) associated with "occult" mastocytosis (SM-AHNMD). p;Report of an unusual case and review of the literature. J Clin Pathol 57:324–328CrossRef Bernd H-W, Sotlar K, Lorenzen J, Osieka R, Fabry U, Valent P, Horny HP (2004) Acute myeloid leukaemia (AML) with t(8;21) associated with "occult" mastocytosis (SM-AHNMD). p;Report of an unusual case and review of the literature. J Clin Pathol 57:324–328CrossRef
Zurück zum Zitat Garcia-Montero AC, Jara-Acevedo M, Teodosio C et al (2006) KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 108(7):2366–2372CrossRef Garcia-Montero AC, Jara-Acevedo M, Teodosio C et al (2006) KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 108(7):2366–2372CrossRef
Zurück zum Zitat Horny HP, Sotlar K, Stellmacher F et al (2006) An unusual case of systemic mastocytosis associated with chronic lymphocytic leukemia (SM-CLL). J Clin Pathol 59(3):264–268CrossRef Horny HP, Sotlar K, Stellmacher F et al (2006) An unusual case of systemic mastocytosis associated with chronic lymphocytic leukemia (SM-CLL). J Clin Pathol 59(3):264–268CrossRef
Zurück zum Zitat Horny HP, Sotlar K, Sperr WR, Valent P (2004) Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge. J Clin Pathol 57(6):604–608CrossRef Horny HP, Sotlar K, Sperr WR, Valent P (2004) Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge. J Clin Pathol 57(6):604–608CrossRef
Zurück zum Zitat Jaffe ES (2001) World Health Organization classification of tumors. Pathology and genetics of tumours of haematopoietic and lymphoid tissues Jaffe ES (2001) World Health Organization classification of tumors. Pathology and genetics of tumours of haematopoietic and lymphoid tissues
Zurück zum Zitat Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH, McClure RF, Li CY, Pardanani A (2009) Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 113(23):5727–5736CrossRef Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH, McClure RF, Li CY, Pardanani A (2009) Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 113(23):5727–5736CrossRef
Zurück zum Zitat Metcalfe DD (1991) Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 96(3):2S–4S Metcalfe DD (1991) Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 96(3):2S–4S
Zurück zum Zitat Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD (1995) Identification of a point mutation in the catalytic domain of the protooncogene c-KIT in the peripheral blood mononuclear cells in patients who have mastocytosis with an associated hematological disorder. Proc Natl Acad Sci U S A 92(23):10560–10564CrossRef Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD (1995) Identification of a point mutation in the catalytic domain of the protooncogene c-KIT in the peripheral blood mononuclear cells in patients who have mastocytosis with an associated hematological disorder. Proc Natl Acad Sci U S A 92(23):10560–10564CrossRef
Zurück zum Zitat Orfao A, Garcia-Montero AC, Sanchez L, Escribano L (2007) Recent advances in the understanding of mastocytosis: the role of KIT mutations. Br J Haematol 138(1):12–30CrossRef Orfao A, Garcia-Montero AC, Sanchez L, Escribano L (2007) Recent advances in the understanding of mastocytosis: the role of KIT mutations. Br J Haematol 138(1):12–30CrossRef
Zurück zum Zitat Parwaresch MR, Homy HP, Lennert K (1985) Tissue mast cells in health and disease. Pathol Res Pract 179(4–5):439–461CrossRef Parwaresch MR, Homy HP, Lennert K (1985) Tissue mast cells in health and disease. Pathol Res Pract 179(4–5):439–461CrossRef
Zurück zum Zitat Sotlar K, Saeger W, Stellmacher F, Stahmer J, Jäckle S, Valent P, Horny HP (2006) “Occult” mastocytosis with activating c-kit mutation evolving into systemic mastocytosis associated with plasma cell myeloma (SM-AHNMD) and secondary amyloidosis. J Clin Pathol 59:875–878CrossRef Sotlar K, Saeger W, Stellmacher F, Stahmer J, Jäckle S, Valent P, Horny HP (2006) “Occult” mastocytosis with activating c-kit mutation evolving into systemic mastocytosis associated with plasma cell myeloma (SM-AHNMD) and secondary amyloidosis. J Clin Pathol 59:875–878CrossRef
Metadaten
Titel
MDS/MPN with ringed sideroblasts and thrombocytosis, and secondary or concurrent mastocytosis: case report and literature review
verfasst von
Ismail Elbaz Younes
Dereen Mohammed Saeed
Nasma Majeed
David Hakimian
Redouane Boumendjel
Publikationsdatum
01.08.2020
Verlag
Springer London
Erschienen in
Comparative Clinical Pathology / Ausgabe 5/2020
Print ISSN: 1618-5641
Elektronische ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-020-03149-1

Weitere Artikel der Ausgabe 5/2020

Comparative Clinical Pathology 5/2020 Zur Ausgabe

Neu im Fachgebiet Pathologie